ST. VINCENTS BLOUNT
1. Target Overview & Investment Thesis
ST. VINCENTS BLOUNT is a 25-bed under-performing / distressed in BLOUNT, AL with $25.2M in net patient revenue and a -33.1% operating margin. The hospital serves a payer mix of 34.6% Medicare, 4.1% Medicaid, and 61.3% commercial.
Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -33.1% to -25.7% (+736bps).
| Net Revenue HCRIS | $25.2M |
| Current EBITDA COMPUTED | $-8.3M |
| Operating Margin COMPUTED | -33.1% |
| Occupancy HCRIS | 42.3% |
| Revenue / Bed COMPUTED | $1.0M |
| Net-to-Gross HCRIS | 30.0% |
| Distress Probability ML | 50.2% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -33.1% places it below the state median. Among 52 size-comparable peers (12-50 beds), the median margin is -15.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 52 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. VINCENTS BLOUNT (Target) | AL | 25 | $25.2M | -33.1% |
| RUSSELL MEDICAL CENTER | AL | 45 | $75.3M | -14.8% |
| JACK HUGHSTON MEMORIAL HOSPITA | AL | 47 | $75.2M | 6.5% |
| NORTH BALDWIN INFIRMARY | AL | 35 | $55.3M | -3.3% |
| HIGHLANDS MEDICAL CENTER | AL | 45 | $45.9M | -30.2% |
| ST. VINCENTS ST. CLAIR | AL | 40 | $40.8M | 8.7% |
| TROY REGIONAL MEDICAL CENTER | AL | 41 | $39.0M | -9.1% |
| WHITFIELD REGIONAL HOSPITAL | AL | 47 | $38.7M | -21.3% |
| RUSSELLVILLE HOSPITAL | AL | 49 | $30.8M | -7.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $528K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $503K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $498K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $306K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $16K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-8.3M |
| + RCM Uplift | +$1.9M |
| Pro Forma EBITDA | $-6.5M |
| Current Margin | -33.1% |
| Pro Forma Margin | -25.7% |
| WC Released (1x) | $965K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-12.8M | $-36.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-12.8M | $-44.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-11.5M | $-42.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-11.5M | $-49.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-14.1M | $-41.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-14.1M | $-50.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 50.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 52 hospitals with 12-50 beds
- Same-state prioritization (n=53)
- Comp margins: P25=-27.2% / P50=-15.9% / P75=-3.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.